Qualcomm Acquires Capsule Technologie
SAN DIEGO – Qualcomm Incorporated (NASDAQ: QCOM) today announced that its subsidiary, Qualcomm Life, Inc., has acquired Capsule Technologie, a leading global provider of medical device integration and clinical data management solutions with more than 1,930 hospital clients in 38 countries. Capsule will become a wholly owned subsidiary of Qualcomm Life.
The acquisition of Capsule extends Qualcomm Life’s connected health offerings into the hospital, ultimately creating a more seamless care continuum from hospital to home and all points in between. By combining Qualcomm Life’s wireless expertise and ecosystem of connected medical devices outside of the hospital with Capsule’s leadership for connecting medical devices, EMR’s and IT systems across the hospital enterprise, Qualcomm Life is creating one of the world’s largest open connected health ecosystems to deliver intelligent care everywhere.
Capsule’s leading medical device integration and clinical data management platform enables data collection, EMR and health IT system integration and monitoring in one of the largest ecosystems of connected devices inside the hospital. Capsule’s smart networking goes beyond device integration by delivering timely clinical data to various in-hospital decision support systems, alarm and notification systems and asset management tools, which help reduce latency and transcription errors to ensure timely, informed care.
“Qualcomm is focused on strengthening its position in specific Internet of Everything verticals, like healthcare,” said Derek Aberle, president, Qualcomm Incorporated. “The acquisition of Capsule expands the breadth of our healthcare platform, enabling us to provide connectivity solutions for the entire care continuum and create one of the world’s largest connected health ecosystems. This will be an important step in advancing the Internet of Medical Things.”
“As health care continues to move into the home and ambulatory settings and outside of traditional care areas such as the hospital, the convergence of medical device data from wherever the patient is located is critically important,” explained Gene Cattarina, CEO, Capsule. “Together, Qualcomm Life and Capsule will power this convergence by making data more accessible and interoperable among care teams to provide true continuity of care at the hospital, in the home and at all points in between.”
About Qualcomm Incorporated
Qualcomm Incorporated (NASDAQ: QCOM) is a world leader in 3G, 4G and next-generation wireless technologies. Qualcomm Incorporated includes Qualcomm’s licensing business, QTL, and the vast majority of its patent portfolio. Qualcomm Technologies, Inc., a wholly-owned subsidiary of Qualcomm Incorporated, operates, along with its subsidiaries, substantially all of Qualcomm’s engineering, research and development functions, and substantially all of its products and services businesses, including its semiconductor business, QCT. For more than 30 years, Qualcomm ideas and inventions have driven the evolution of digital communications, linking people everywhere more closely to information, entertainment and each other. For more information, visit Qualcomm’s website, OnQ blog, Twitter and Facebook pages.
This news release contains forward-looking statements that are subject to risks, uncertainties and assumptions. Actual results could differ materially from those expressed or implied by such forward-looking statements. All statements other than those of historical fact could be deemed forward-looking statements, including but not limited to statements regarding: the expected benefits of the transaction; management plans relating to the transaction; the plans, strategies and objectives of management for future operations; product development, product extensions, product integration, new products, sales channels and customers, complementary product offerings and growth opportunities in certain business areas, including the Internet of Medical Things; the potential future financial impact of the transaction; and any assumptions underlying any of the foregoing. Actual results may differ materially from those referred to in the forward-looking statements due to a number of important factors, including but not limited to the possibility that expected benefits of the transaction may not materialize as expected; that Qualcomm Life may not be able to successfully integrate the products and employees of Capsule or ensure the continued performance or growth of Capsule’s products; as well as the other risks detailed from time to time in Qualcomm’s SEC reports, including its most recent Quarterly Report on Form 10-Q for the period ended June 28, 2015. Qualcomm does not undertake any obligation to update, or continue to provide information with respect to, any forward-looking statement, whether as a result of new information, future events or otherwise.
Qualcomm Contacts:
Emily Kilpatrick, Corporate Communications
Phone: 1-858-845-5959
Email: corpcomm@qualcomm.com
Jamie Eisinger, Qualcomm Life, Inc.
Phone: 1-858-845-1033
Email: jeisinge@qti.qualcomm.com
Warren Kneeshaw, Investor Relations
Phone: 1-858-658-4813
Email: ir@qualcomm.com
